AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8200
-0.0600 (-6.82%)
At close: May 13, 2026, 4:00 PM EDT
0.8017
-0.0183 (-2.23%)
After-hours: May 13, 2026, 8:00 PM EDT
AEON Biopharma Employees
AEON Biopharma had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$4,902,750
Market Cap
21.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% |
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Jun 30, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Jun 30, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 8 | - | - |
| Sep 30, 2022 | 9 | 3 | 50.00% |
| Jun 30, 2021 | 6 | - | - |
| Mar 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| Longeveron | 38 |
| Curis | 24 |
| ABVC BioPharma | 19 |
| Outlook Therapeutics | 17 |
| Lantern Pharma | 16 |
| Serina Therapeutics | 13 |
| VYNE Therapeutics | 10 |
AEON News
- 19 days ago - AEON Biopharma Sets Annual Shareholder Meeting - GlobeNewsWire
- 5 weeks ago - Aeon receives additional notice related to NYSE American listing standards - TheFly
- 5 weeks ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 5 weeks ago - AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - GlobeNewsWire
- 6 weeks ago - AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program - GlobeNewsWire
- 7 weeks ago - Aeon Biopharma announces FDA feedback after Type 2a meeting - TheFly
- 2 months ago - Aeon Biopharma appoints John Bencich as CFO - TheFly
- 3 months ago - Aeon Biopharma files to sell 51.29M shares of Class A common stock for holders - TheFly